ici 118551 and okadaic acid

ici 118551 has been researched along with okadaic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gomi, S; Hirose, M; Hongo, M; Kashihara, T; Nakada, T; Shimojo, H; Yamada, M	1

Other Studies

1 other study(ies) available for ici 118551 and okadaic acid

Article	Year
β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure. European journal of pharmacology, 2014, Feb-05, Volume: 724 Topics: Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Calcium Channels, L-Type; Enzyme Inhibitors; Heart Failure; Male; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Myocardial Contraction; Okadaic Acid; Phosphoprotein Phosphatases; Propanolamines; Receptor, Muscarinic M2; Receptors, Adrenergic, beta-2; Ventricular Function, Left; Xanthines	2014

Article

Year

β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure.

European journal of pharmacology, 2014, Feb-05, Volume: 724

Topics: Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Calcium Channels, L-Type; Enzyme Inhibitors; Heart Failure; Male; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Myocardial Contraction; Okadaic Acid; Phosphoprotein Phosphatases; Propanolamines; Receptor, Muscarinic M2; Receptors, Adrenergic, beta-2; Ventricular Function, Left; Xanthines

2014